The human isoform proteomeProtein variants such as splice variants, post-translational modifications (PTMs), proteolytic products, genetic variations and somatic recombination dramatically expand the proteomic diversity beyond the size of the human genome, and a single gene can have more than 100 different proteoforms. The term proteoform include all type of variants, but the subset originating from pre-translational alterations at the gene or mRNA level are usually called isoforms. Different proteoforms can have have different activity, subcellular location or function, or be tailored for specific tissues or developmental stages. Splice variantsAlternative splicing is a widely used mechanism for the formation of isoforms and 76% of the human protein-coding genes have more than one splice variant, while 1539 have more than 10. Splicing occurs during gene expression and in this process the exons of a gene may be included or excluded in the processed mRNA. Proteins translated from alternatively spliced mRNAs will therefore contain differences in their amino acid sequence, and can therefore also differ in their functional properties. In total there are 89866 isoforms in the HPA gene set based on Ensembl version 109 . The four major subtypes of alternative splicing:
Figure 1. The major types of alternative splicing. Alternative splicing can affect the location of a protein by including or excluding e.g. nuclear localization signals, organelle targeting peptides or transmembrane regions. Many genes encode for multiple splice variants with alternative predicted locations, including 237 genes with both secreted and membrane-bound isoforms. In Figure 2, the fractions of the various categories are shown for all 20162 genes.
Figure 2. Venn diagram showing the overlap between the number of genes that are intracellular, membrane-spanning, secreted, or with isoforms belonging to more than one of the three categories. Splice variants can also alter subcellular localization, enzyme activity, signaling affinities or protein function. A well-known example of the latter is the BCL2L1 gene involved in programmed cell death, which produces both an anti-apoptotic isoform( Bcl-xL) and a pro-apoptotic isoform (Bcl-xS). Genetic variationsHumans are almost identical biochemically (99.9%), still there are large variations between individuals in the population as a result of allele-specific genetic variations in the protein-coding regions. Genetic variants are differences in the DNA sequence compared to a reference genome, and they include single-nucleotide variants (SNVs), insertion and deletions (indels) and structural variants (SVs). Knowledge and mapping of genetic variants can be important in disease risk assessment, disease diagnosis and targeted gene therapies, but also as a tool for understanding human history. SNVs are the most common type of genetic variation and if an SNV is present in more than 1% of the population it is called a single nucleotide polymorphism (SNP). Based on Ensembl Variation 3557 genes have determined population and/or clinical genetic variants, and in the 1000 Genomes Project more than 500,000 SNVs, including ~50,000 SNPs in protein-coding regions have been reported among the individuals. Explore Genetic variants in the Structure resource Somatic recombinationSomatic recombination is a mechanism of genetic recombination that is unique to the immunoglobulin and T-cell receptor genes. In this process immunoglobulins and T-cell receptors of high diversity are produced. At any given time there are tens of million different IgG-molecules in a human body due to the elaborate process of somatic recombination and targeted mutation. Post-translational modifications (PTMs)Post-translational modifications(PTMs) are chemical or proteolytic modifications that change proteins following their synthesis and release from the ribosomes.They enable protein diversification and modification of protein function beyond the genetic encoding by attaching molecules such as phosphate, carbohydrates or lipids, or by changing existing functional groups. PTMs are important in many biological processes such as protein folding and maturation, modulation of enzyme activity, protein localization, regulation of degradation and alteration of protein-protein interactions. PTMs occur at distinct amino acid side chains or peptide linkages and are most often mediated by enzymatic activity. 18113 genes have at least one experimentally verified chemical modification resulting from six common types of PTMs. Read more about some common types of PTMs Explore PTMs in the Structure resource Proteolytic modificationsAfter translation, some proteins undergo proteolytic processing. This process is highly specific and as a result of the cleavage of one or more bonds in the target protein by proteases, the activity of the protein will be altered. A large number of proteins are synthesized as inactive precursors, so called proproteins. To activate these proteins, removal of the propeptide via proteolytic processing is needed. Proteolysis of the precursor proteins will result in regulation of many cellular processes. Well-studied proteins that undergo this process are insulin (INS) and factor VIII (F8). Relevant links and publications Uhlén M et al., Tissue-based map of the human proteome. Science (2015) |